Induction of dermal and subcutaneous inflammation by recombinant cachectin/tumor necrosis factor (TNF alpha) in the mouse.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Investigative Dermatology

• Publication date

  1988-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/1523-1747.EP12475754PMID 3171214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo administration of interleukin 1 to normal mice depresses their capacity to elicit contact hypersensitivity responses: prostaglandins are involved in this modification of immune function.

  1987cited by this paper
• Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury.

  1987cited by this paper
• Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin

  1987cited by this paper
• Cachectin: more than a tumor necrosis factor.

  1987cited by this paper
• Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

  1987cited by this paper
• Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

  1986cited by this paper
• Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

  1986cited by this paper
• Shock and tissue injury induced by recombinant human cachectin.

  1986cited by this paper
• Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins.

  1986cited by this paper
• Stimulation of neutrophils by tumor necrosis factor.

  1986cited by this paper
• Cachectin and tumour necrosis factor as two sides of the same biological coin

  1986cited by this paper
• Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors

  1986cited by this paper
• Involvement of prostaglandins in the immune alterations caused by the exposure of mice to ultraviolet radiation.

  1986cited by this paper
• In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse.

  1986cited by this paper
• Circuits and signals of the skin-associated lymphoid tissues (SALT).

  1985cited by this paper
• Effect of tumour necrosis factor on growth of Ehrlich ascites tumour cells in vitro and in vivo.

  1985cited by this paper
• Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

  1985cited by this paper
• Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

  1985cited by this paper
• Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts.

  1985cited by this paper
• Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

  1985cited by this paper
• Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

  1985cited by this paper
• Epidermal cytokines: properties of epidermal cell thymocyte-activating factor (ETAF).

  1984cited by this paper
• Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

  1984cited by this paper
• Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

  1984cited by this paper
• Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).

  1981cited by this paper
• Detection of endotoxin in human blood and demonstration of an inhibitor.

  1970cited by this paper

• Characterization and Validation of Arg286 Residue of IL-1RAcP as a Potential Drug Target for Osteoarthritis

  2021cites this paper
• PKCζ as a promising therapeutic target for TNFα-induced inflammatory disorders in chronic cutaneous wounds

  2017cites this paper
• LPS-induced cytokine production in human monocytes and macrophages.

  2011cites this paper
• Taxane-induced morphea in a patient with CREST syndrome

  2010cites this paper
• Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFα prevents radiation-induced fibrosis.

  2010cites this paper
• A Case of Systemic Sclerosis Occurring after Paclitaxel Therapy

  2009cites this paper
• Gamma Interferon Induced Organ Regeneration

  2008cites this paper
• Taxane‐induced scleroderma

  2007cites this paper
• A systematic review of the safety of topical therapies for atopic dermatitis

  2007cites this paper
• Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis

  2007cites this paper
• Absence of tumor necrosis factor-α in suction blister fluids and stratum corneum from patients with psoriasis

  2004cites this paper
• Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the Tnfa and Lps loci governs susceptibility

  2004cites this paper
• Tumour necrosis factor‐α‐induced migration of human Langerhans cells: the influence of ageing

  2002cites this paper
• Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing.

  2002cites this paper
• Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study.

  2001cites this paper
• TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype.

  2000cites this paper
• TGF-β1 and IFN-γ Direct Macrophage Activation by TNF-α to Osteoclastic or Cytocidal Phenotype1

  2000cites this paper
• Cytocidal Phenotype to Osteoclastic or α Activation by TNF-Direct Macrophage γ and IFN-1 β TGF-Lean and

  2000cites this paper
• Vitamin C abrogates the deleterious effects of UVB radiation on cutaneous immunity by a mechanism that does not depend on TNF-alpha.

  1997cites this paper
• Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF‐α‐induced skin inflammation

  1997cites this paper
• In situ changes in the relative abundance of human epidermal cytokine messenger RNA levels following exposure to the poison ivy/oak contact allergen urushiol

  1996cites this paper
• Tumour necrosis factor alpha is pro‐inflammatory in normal human skin and modulates cutaneous adhesion molecule expression

  1995cites this paper
• Messenger RNAs for the multifunctional cytokines interleukin‐1α, interleukin‐1β and tumor necrosis factor‐α are present in adnexal tissues and in dermis of normal human skin

  1995cites this paper
• A comparative study of the mechanisms leading to dermal and lung disease in systemic sclerosis.

  1995cites this paper
• Evidence that ultraviolet B radiation induces tolerance and impairs induction of contact hypersensitivity by different mechanisms.

  1994cites this paper
• Cis-urocanic acid stimulates human peripheral blood monocyte prostaglandin E2 production and suppresses indirectly tumor necrosis factor-alpha levels.

  1993cites this paper
• Immunogenetic influences on the initiation stage of the cutaneous chemical carcinogenesis pathway.

  1992cites this paper
• Effective regional therapy of experimental cancer with paralesional administration of tumour necrosis factor-α + interferon-γ

  1992cites this paper
• Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.

  1992cites this paper
• Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts.

  1992cites this paper
• Tumour necrosis factor-alpha mediates ultraviolet light B-enhanced expression of contact hypersensitivity.

  1992cites this paper
• Effective regional therapy of experimental cancer with paralesional administration of tumour necrosis factor-alpha + interferon-gamma.

  1992cites this paper
• Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride.

  1991cites this paper
• Tumor necrosis factor alpha inhibits wound healing in the rat.

  1991cites this paper
• Inflammation and endothelial cells.

  1991cites this paper
• X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.

  1991cites this paper
• Interleukin 6 inhibits delayed‐type hypersensitivity and the development of adjuvant arthritis

  1991cites this paper
• Cytokine inhibition by a novel steroid, mometasone furoate.

  1991cites this paper
• Soluble immunologic products in scleroderma sera.

  1991cites this paper
• Tumor necrosis factor.

  1991cites this paper
• Interleukin-1 and tumour necrosis factor α induced polymorphonuclear leukocyte-endothelial cell adhesion and transendothelial migration in vitro: the effect of apical versus basal monolayer stimulation

  1990cites this paper
• Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide

  1990cites this paper
• Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis.

  1990cites this paper
• Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4.

  1990cites this paper
• Interleukin-1 and tumour necrosis factor alpha induced polymorphonuclear leukocyte-endothelial cell adhesion and transendothelial migration in vitro: the effect of apical versus basal monolayer stimulation.

  1990cites this paper
• Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions.

  1990cites this paper
• Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-alpha.

  1989cites this paper
• [Tumor necrosis factor (TNF) and pathology; its relationships with other cytokines].

  1989cites this paper
• Recombinant Human Tumour Necrosis Factor β (Lymphotoxin) Lacks Chemotactic Activity for Human Peripheral Blood Neutrophils, Monocytes, and T Cells

  1989cites this paper
• Chapter 24. Exogenous Growth Factors in Dermal Wound Healing

  1989cites this paper
• Macrophages Are a Major Source Offibrogenic Factors That Stimulation of Fibroblast Chemotaxis by Human Recombinant Tumor Necrosis Factor a (tnf-cx) and a Synthetic Tnf-a 31-68 Peptide

  year unknowncites this paper
• Anabolic effect of estrogen replacement on bone in Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: Histomorphometric postmenopausal women with osteoporosis: Histomorphometric evidence in a longitudinal study. evidence in a longitudinal study.

  year unknowncites this paper
• TGF-beta and IFN-gamma direct macrophage activation by TNF-TGF-beta and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype. alpha to osteoclastic or cytocidal phenotype.

  year unknowncites this paper